The study describes experiments on bone and bone marrow sections, immunostaining, and BrdU-LTR assays to analyze hematopoietic stem cells (HSCs). Mice were fed BrdU for 10 days, and 40% of LT-HSCs divided. Sections were stained with anti-BrdU antibody 70 days later. N-cadherin-positive cells were quantified using AEC staining and three independent counts. High-resolution X-ray images were taken using a Faxitron MX-20 machine. The study also references several prior works on hematopoietic stem cells, bone morphogenetic proteins, and Notch signaling. The paper "Osteoblastic cells regulate the haematopoietic stem cell niche" investigates how osteoblastic cells influence hematopoietic stem cells (HSCs) through Notch signaling. Transgenic mice with activated PTH/PTHrP receptors (PPRs) showed increased numbers of trabeculae and HSCs. These mice had higher levels of the Notch ligand Jagged 1 and supported more HSCs. PTH treatment increased osteoblast numbers and enhanced primitive hematopoietic cell growth. Notch activation was confirmed by increased NICD levels in HSCs. γ-secretase inhibition reduced the supportive capacity of transgenic stroma. PTH treatment improved survival after bone marrow transplantation, indicating that osteoblastic cells regulate the HSC niche through Notch activation. The study also shows that PTH treatment increases the number of HSCs in wild-type mice and improves engraftment in secondary recipients. PTH treatment did not affect hematopoietic progenitors as measured by CFU-C. The results suggest that PTH activates PPR in osteoblastic cells, leading to increased Jag1 production and Notch activation, which expands the HSC compartment. The study highlights the importance of the osteoblast niche in regulating HSC function and provides a pharmacological target for stem cell-based therapies. The paper also discusses the role of the bone marrow microenvironment in hematopoiesis, with osteoblasts producing growth factors and being activated by PTH or PTHrP. The study demonstrates that osteoblastic cells are a regulatory component of the HSC niche, influencing stem cell function through Notch signaling. The findings have implications for stem cell expansion and therapy. The study is supported by various references to prior research on hematopoietic stem cells, Notch signaling, and bone morphogenetic proteins.The study describes experiments on bone and bone marrow sections, immunostaining, and BrdU-LTR assays to analyze hematopoietic stem cells (HSCs). Mice were fed BrdU for 10 days, and 40% of LT-HSCs divided. Sections were stained with anti-BrdU antibody 70 days later. N-cadherin-positive cells were quantified using AEC staining and three independent counts. High-resolution X-ray images were taken using a Faxitron MX-20 machine. The study also references several prior works on hematopoietic stem cells, bone morphogenetic proteins, and Notch signaling. The paper "Osteoblastic cells regulate the haematopoietic stem cell niche" investigates how osteoblastic cells influence hematopoietic stem cells (HSCs) through Notch signaling. Transgenic mice with activated PTH/PTHrP receptors (PPRs) showed increased numbers of trabeculae and HSCs. These mice had higher levels of the Notch ligand Jagged 1 and supported more HSCs. PTH treatment increased osteoblast numbers and enhanced primitive hematopoietic cell growth. Notch activation was confirmed by increased NICD levels in HSCs. γ-secretase inhibition reduced the supportive capacity of transgenic stroma. PTH treatment improved survival after bone marrow transplantation, indicating that osteoblastic cells regulate the HSC niche through Notch activation. The study also shows that PTH treatment increases the number of HSCs in wild-type mice and improves engraftment in secondary recipients. PTH treatment did not affect hematopoietic progenitors as measured by CFU-C. The results suggest that PTH activates PPR in osteoblastic cells, leading to increased Jag1 production and Notch activation, which expands the HSC compartment. The study highlights the importance of the osteoblast niche in regulating HSC function and provides a pharmacological target for stem cell-based therapies. The paper also discusses the role of the bone marrow microenvironment in hematopoiesis, with osteoblasts producing growth factors and being activated by PTH or PTHrP. The study demonstrates that osteoblastic cells are a regulatory component of the HSC niche, influencing stem cell function through Notch signaling. The findings have implications for stem cell expansion and therapy. The study is supported by various references to prior research on hematopoietic stem cells, Notch signaling, and bone morphogenetic proteins.